The involvement of multidrug and toxin extrusion protein 1 in the distribution and excretion of berberine

References

• Ahmadiankia N, Moghaddam HK, Mishan MA, et al. (2016). Berberine suppresses migration of MCF-7 breast cancer cells through down-regulation of chemokine receptors. Iran J Basic Med Sci 19:125–31
   PubMed Web of Science ®Google Scholar
• Alexander RT, Dimke H, Cordat E. (2013). Proximal tubular NHEs: sodium, protons and calcium? Am J Physiol Renal Physiol 305:F229–36
   PubMed Web of Science ®Google Scholar
• Chang XX, Yan HM, Xu Q, et al. (2012). The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet. Lipids Health Dis 11:86
   PubMed Web of Science ®Google Scholar
• Chen C, Wu ZT, Ma LL, et al. (2015). Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine. Xenobiotica 45:1138–46
   PubMed Web of Science ®Google Scholar
• Chen CM, Chang HC. (1995). Determination of berberine in plasma, urine and bile by high-performance liquid chromatography. J Chromatogr B 665:117–23
   PubMed Web of Science ®Google Scholar
• Chen Y, Teranishi K, Li S, et al. (2009). Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function. Pharmacogenom J 9:127–36
   PubMed Web of Science ®Google Scholar
• Cho SK, Chung JY. (2016). The MATE1 rs2289669 polymorphism affects the renal clearance of metformin following ranitidine treatment. Int J Clin Pharmacol Therap 54:253–62
   PubMed Web of Science ®Google Scholar
• Dangprapai Y, Wright SH. (2011). Interaction of H + with the extracellular and intracellular aspects of hMATE1. Am J Physiol Renal Physiol 301:F520–8
   PubMed Web of Science ®Google Scholar
• DeGorter MK, Xia CQ, Yang JJ, Kim RB. (2012). Drug transporters in drug efficacy and toxicity. Annu Rev Pharmacol Toxicol 52:249–73
   PubMed Web of Science ®Google Scholar
• Dong H, Wang N, Zhao L, Lu F. (2012). Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med 2012:591654
   PubMed Web of Science ®Google Scholar
• Hiasa M, Matsumoto T, Komatsu T, Moriyama Y. (2006). Wide variety of locations for rodent MATE1, a transporter protein that mediates the final excretion step for toxic organic cations. Am J Physiol Cell Physiol 291:C678–86
   PubMed Web of Science ®Google Scholar
• Imanshahidi M, Hosseinzadeh H. (2008). Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 22:999–1012
   PubMed Web of Science ®Google Scholar
• Ito S, Kusuhara H, Kuroiwa Y, et al. (2010). Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine. J Pharmacol Exp Therap 333:341–50
   PubMed Web of Science ®Google Scholar
• Ito S, Kusuhara H, Yokochi M, et al. (2012). Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug–drug interactions caused by cimetidine in the kidney. J Pharmacol Exp Therap 340:393–403
   PubMed Web of Science ®Google Scholar
• Jin Y, Khadka DB, Cho WJ. (2016). Pharmacological effects of berberine and its derivatives: a patent update. Expert Opin Therap Patents 26:229–43
   PubMed Web of Science ®Google Scholar
• Karaosmanoglu K, Sayar NA, Kurnaz IA, Akbulut BS. (2014). Assessment of berberine as a multi-target antimicrobial: a multi-omics study for drug discovery and repositioning. Omics 18:42–53
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Ito S, Kumagai Y, et al. (2011). Effects of a MATE protein inhibitor, pyrimethamine, on the renal elimination of metformin at oral microdose and at therapeutic dose in healthy subjects. Clin Pharmacol Therap 89:837–44
   PubMed Web of Science ®Google Scholar
• Kwon M, Choi YA, Choi MK, Song IS. (2015). Organic cation transporter-mediated drug–drug interaction potential between berberine and metformin. Arch Pharmacal Res 38:849–56
   PubMed Web of Science ®Google Scholar
• Lei HM, Sun SY, Li LP, et al. (2015). [Establishment of MDCK cell models expressing human MATE1 or co-expressing with human OCT1 or OCT2]. Acta Pharma Sinica 50:842–7
   PubMedGoogle Scholar
• Leslie EM, Watkins PB, Kim RB, Brouwer KL. (2007). Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1) by bosentan: a mechanism for species differences in hepatotoxicity. J Pharmacol Exp Therap 321:1170–8
   PubMed Web of Science ®Google Scholar
• Liu B, Li W, Chang Y, et al. (2006). Extraction of berberine from rhizome of Coptis chinensis Franch using supercritical fluid extraction. J Pharma Biomed Analysis 41:1056–60
   PubMed Web of Science ®Google Scholar
• Liu X, Chism JP, LeCluyse EL, et al. (1999a). Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats. Drug Metab Dispos 27:637–44
   PubMed Web of Science ®Google Scholar
• Liu X, LeCluyse EL, Brouwer KR, et al. (1999b). Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes. J Pharmacol Exp Therap 289:1592–9
   PubMed Web of Science ®Google Scholar
• Liu YT, Hao HP, Xie HG, et al. (2010). Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos 38:1779–84
   PubMed Web of Science ®Google Scholar
• Lundquist P, Loof J, Fagerholm U, et al. (2014). Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model. Drug Metab Dispos 42:459–68
   PubMed Web of Science ®Google Scholar
• Ma JY, Feng R, Tan XS, et al. (2013). Excretion of berberine and its metabolites in oral administration in rats. J Pharma Sci 102:4181–92
   PubMed Web of Science ®Google Scholar
• Maeng HJ, Yoo HJ, Kim IW, et al. (2002). P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J Pharma Sci 91:2614–21
   PubMed Web of Science ®Google Scholar
• Metcalf Pate KA, Lyons CE, Dorsey JL, et al. (2013). Platelet activation and platelet-monocyte aggregate formation contribute to decreased platelet count during acute simian immunodeficiency virus infection in pig-tailed macaques. J Infect Dis 208:874–83
   PubMed Web of Science ®Google Scholar
• Minematsu T, Giacomini KM. (2011). Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins. Mol Cancer Therap 10:531–9
   PubMed Web of Science ®Google Scholar
• Moriyama Y, Hiasa M, Matsumoto T, Omote H. (2008). Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics. Xenobiotica 38:1107–18
   PubMed Web of Science ®Google Scholar
• Motohashi H, Inui K. (2013). Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K. Mol Aspects Med 34:661–8
   PubMed Web of Science ®Google Scholar
• Nies AT, Herrmann E, Brom M, Keppler D. (2008). Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). Naunyn–Schmiedeberg's Archiv Pharmacol 376:449–61
   PubMed Web of Science ®Google Scholar
• Otsuka M, Matsumoto T, Morimoto R, et al. (2005). A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci USA 102:17923–8
   PubMed Web of Science ®Google Scholar
• Pan GY, Wang GJ, Liu XD, et al. (2002). The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 91:193–7
   PubMedGoogle Scholar
• Pfeifer ND, Yang K, Brouwer KL. (2013). Hepatic basolateral efflux contributes significantly to rosuvastatin disposition I: characterization of basolateral versus biliary clearance using a novel protocol in sandwich-cultured hepatocytes. J Pharmacol Exp Therap 347:727–36
   PubMed Web of Science ®Google Scholar
• Staud F, Cerveny L, Ahmadimoghaddam D, Ceckova M. (2013). Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics. Int J Biochem Cell Biol 45:2007–11
   PubMed Web of Science ®Google Scholar
• Swift B, Pfeifer ND, Brouwer KL. (2010). Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 42:446–71
   PubMed Web of Science ®Google Scholar
• Tan XS, Ma JY, Feng R, et al. (2013). Tissue distribution of berberine and its metabolites after oral administration in rats. PloS One 8:e77969
   PubMed Web of Science ®Google Scholar
• Tanihara Y, Masuda S, Sato T, et al. (2007). Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem Pharmacol 74:359–71
   PubMed Web of Science ®Google Scholar
• Terada T, Inui K. (2008). Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A). Biochem Pharmacol 75:1689–96
   PubMed Web of Science ®Google Scholar
• Wang L, Prasad B, Salphati L, et al. (2015a). Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics. Drug Metab Dispos 43:367–74
   PubMed Web of Science ®Google Scholar
• Wang X, Wang S, Ma J, et al. (2015b). Pharmacokinetics in rats and tissue distribution in mouse of berberrubine by UPLC-MS/MS. J Pharma Biomed Analysis 115:368–74
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen Z, Yang S, et al. (2014). Berberine ameliorates collagen-induced arthritis in rats associated with anti-inflammatory and anti-angiogenic effects. Inflammation 37:1789–98
   PubMed Web of Science ®Google Scholar
• Watanabe S, Tsuda M, Terada T, et al. (2010). Reduced renal clearance of a zwitterionic substrate cephalexin in MATE1-deficient mice. J Pharmacol Exp Therap 334:651–6
   PubMed Web of Science ®Google Scholar
• Wu ZT, Qi XM, Sheng JJ, et al. (2014). Timosaponin A3 induces hepatotoxicity in rats through inducing oxidative stress and down-regulating bile acid transporters. Acta Pharmacol Sinica 35:1188–98
   PubMed Web of Science ®Google Scholar
• Xia X, Wang H, Niu X, et al. (2014). Assessment of the anti-diarrhea function of compound Chinese herbal medicine Cangpo Oral Liquid. Afr J Traditional Complement Alternat Med 11:140–7
   PubMed Web of Science ®Google Scholar
• Yonezawa A, Inui K. (2011). Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics. Br J Pharmacol 164:1817–25
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski MJ, Bao JQ, Day JS, Higgins JW. (2013). Metformin sinusoidal efflux from the liver is consistent with negligible biliary excretion and absence of enterohepatic cycling. Drug Metab Dispos 41:1967–71
   PubMed Web of Science ®Google Scholar
• Zheng J, Woo SL, Hu X, et al. (2015). Metformin and metabolic diseases: a focus on hepatic aspects. Front Med 9:173–86
   PubMed Web of Science ®Google Scholar